following editorial errors should be corrected. On p. 6105, in Table 2 , lines 5 and 6 should read "AcMur-L-Ala-D-Gln Me ester" and "AcMur-L-Ala-D-Gln n-Bu ester," respectively, and the last sentence in the legend should read "The amount of glutamic acid released by hydrolysis was used to calculate the dose." On the same page, in the right-hand column, line 28 should read "esters and the N-Me derivative of AcMur-Ala-Gln.
A sleep-promoting factor derived from human urine has recently been described by Krueger et aL (1, 2) . Correlation of amino acid and amino sugar analyses with sleep-promoting activities of purified fractions indicated that the sleep factor contained muramic acid, alanine, glutamic acid, and diaminopimelic acid. Chemical and physiological properties ofthe urinary factor resemble those of the sleep factor found in sterile cerebrospinal fluid and in acid/acetone extracts of brains from sleep-deprived animals (2, 3) . In rabbits, intraventricular infusion of10 pmol ofthe pure factor induces excess slow-wave sleep (SWS) for [5] [6] [7] [8] [9] [10] hr after the infusion. The effects are primarily on the duration of SWS and on the amplitude of cortical slow waves; there is relatively little effect on rapid eye movement (REM) sleep. The excess SWS appears to be normal from a behavioral point ofview; the animals can easily be aroused by noise or, if left to themselves, awaken spontaneously from time to time to eat, drink, and groom. Microinjection studies indicate that the site of action of the sleep factor is localized to a region between the basal forebrain and the mesodiencephalic junction (4) .
Muramic acid and diaminopimelic acid are constituents of polymeric peptidoglycans in the cell walls of bacteria and the subunits are immunostimulants and pyrogens (5) . ' The simplest synthetic analog that has both immunostimulatory and pyrogenic effects is N-acetylmuramyl-L-alanyl-D-isoglutamine (AcMur-Ala-iGln, "muramyl dipeptide"; ref. 6 ) and many derivatives of this basic structure have been examined for their immunological and pyrogenic properties (5, 7, 8) . Our discovery that the composition of sleep factor purified from brain or from urine is closely related to bacterial peptidoglycans led us to investigate the effects of some synthetic muramyl peptides on sleep. In the present paper, we show that AcMur-Ala-iGln and the tripeptide AcMur-Ala-iGln-Lys can mimic the sleep-promoting effects of sleep factor, although the response may be modified by pyrogenic effects and by other disturbances ofautonomic function.
MATERIALS AND METHODS
AcMur-Ala-iGln and its derivatives were gifts from E. Lederer (Universit6 de Paris-Sud 91405 Orsay Cedex) and from P. Lefrancier (Institut Choay). The purity of these materials was checked by amino acid and amino sugar analyses of unhydrolyzed and hydrolyzed (6 M HCl, 1000C, 6 hr) samples using a Beckman 121 MB analyzer.
Surgical procedures for implantation of ventricular guide tubes and electroencephalogram (EEG)/EOG electrodes have been described (9, 10) . Calibrated glass bead thermistors (Fenwall; 1.2-mm outside diameter, 50 fl/'C) were implanted through burr holes in frontal bone: the thermistor leads were buried in a mound 6fdental cement that also insulated the screw electrodes and supported a 9-pin miniature electrical connector. In some experiments, the rectal temperatures were measured at intervals by using a calibrated thermistor probe; temperatures estimated from the implanted brain thermistors were generally within 0.30C of simultaneously recorded rectal temperature.
New Zealand rabbits (male, 3-5 kg) or domestic cats were adapted to the infusion cages in a temperature-controlled room (21 ± 20C) on a 12:12 light/dark cycle. Intraventricular infusions or systemic injections were carried out between 0800 and 1000 hr and were followed by 6 values of about 40% to about 60% for 6 hr or more after the infusion. The amplitude of slow waves during episodes of SWS was increased and there was an increase of 1 to 2TC in body temperature. The results obtained in a single experiment using AcMur-Ala-iGln-Lys are shown in Fig. 1 , and similar results obtained from 12 rabbits given either AcMur-Ala-iGln or AcMur-Ala-iGln-Lys are summarized in Table 1 . The somnogenic effects of AcMur-Ala-iGln resemble those elicited by factor S but the amount of synthetic peptide required to induce a comparable increase of SWS for 6 hr is roughly 10 times that of the natural product.
The excess sleep induced by intraventricular administration ofAcMur-Ala-iGln or ofAcMur-Ala-iGln-Lys in rabbits appears to be normal in spite of the development offever. The episodic nature of sleep is retained and the induced excess sleep results primarily from an increase in the number of sleep episodes lasting for more than 8 min (Fig. 2) Effects of Intravenous, Intraperitoneal, and Enteric AcMurAla-iGIn. Systemic administration of AcMur-Ala-iGIn induces a febrile response in rabbits (8, 12) , and we now report that somnogenic effects ean also be elicited by intravenous and intraperitoneal injection or by administration via stomach tube. The' average magnitude and time course of the somnogenic effects of AcMur-Ala-iGln administered intravenously to rabbits in doses of 150-200 nmol/kg (75-100 ,g) is shown in Fig. 4 .
The sleep response reaches a maximum about 3 hr after injec-'tion and returns to near control values within 5 hr. During the first 3 hr, including the period of maximum sleep, the animals appear normal in the sense that they can be aroused easily and respond to handling. After 3 to 4 hr, however, the animals become unresponsive and may fail to open their eyes even when they are awake. In some animals, we noted abnormal lacrimation, nasal secretion, and inflammation of the conjunctiva.
Evidently, the relatively large doses of AcMur-Ala-iGln required to induce pyrogenic or somnogenic effects via the intravenous route also cause. disturbances of other autonomic functions: other deleterious effects of AcMur-Ala-iGln have been reviewed by Lederer (5) . Masek et aL (13) reported that intravenous injection of bacterial peptidoglycans or of AcMurAla-iGln can cause suppression of REM sleep in rats for several hours; it may be that, in this species, as in the cat (Fig. 3) Time after infusion, hr initial effect of AcMur-Ala-iGIn is inhibitory.
In two rabbits, we recorded sleep responses after intraperitoneal injection of AcMur-Ala-iGln (160 ,tg/kg) and, in another two rabbits, sleep responses were recorded after administration of AeMur-Ala-iGln by stomach tube (5 mg/kg). Substantial sleep responses (ca. 50% increase of SWS for 6 hr) were noted in both cases. Effects of Indomethacin and Acetaminophen. The time course ofthe pyrogenic response to AcMur-Ala-iGln was sometimes quite different from that of the somnogenic response and in some animals the natural muramyl peptide isolated from urine induced substantial excess SWS without significant alterations of temperature. This suggested the possibility that the somnogenic effect ofAcMur-Ala-iGln might be dissociated from o, AAP alone; *, AAP followed by 120 gg of AcMur-Ala-iGln intravenously at time zero. Each value is mean SEM of six assays in six rabbits. In A, the average of the individual increases (AT values) in rectal temperature induced by AcMur-Ala-iGln together with AAP is compared with that induced by AAP alone in each of six rabbits. AAP alone had no significant effects on either sleep or rectal temperature nor did it block the sleep-inducing effects of AcMur-Ala-iGln [hourly % SWS: AAP alone, 41 3 (mean + SEM); AAPtogetherwithAcMur-Ala-iGln, 67 3]. However, the pyrogenic effects of AcMur-Ala-iGln were completely or partially suppressed by AAP. The average AT after AcMur-Ala-iGln together with AAP was <0.7°C as compared with 1.9 0.2°C after AcMur-AlaiGln alone (Table 1) . NS, not significant. its pyrogenic effect by previous treatment with antipyretics. In preliminary experiments, we used indomethacin as an antipyretic because Parant et al. (14) had shown that this drug (in doses of 40 mg/kg) was effective in blocking the pyrogenic response to intravenously administered AcMur-Ala-iGln. However, we found that indomethacin alone caused toxic reactions in rabbits and cats, even in doses as low as 1 mg/kg; toxic reactions included diarrhea, lethargy, and inhibition of normal sleep. For this reason, we used the less toxic acetaminophen to suppress the pyrogenic effects ofAcMur-Ala-iGln. The results for six rabbits injected intravenously with AcMur-Ala-iGln at 120 ,ug/kg 30 min after intravenous injection of acetaminophen at 10 mg/ kg are summarized in Fig. 5 . It is clear that, under these conditions, a substantial somnogenic effect was obtained for 3 to 4 hr with only a weak associated febrile response. In some animals, there was no significant increase in temperature during the sleep response. After about 4 hr, the animals developed toxic reactions similar to those that follow the intravenous administration of AcMur-Ala-iGln alone.
Indomethacin failed to block either the pyrogenic or the somnogenic effects of intraventricularly administered AcMur-AlaiGln in 10 out of 10 trials in six rabbits. Similar results were obtained with acetaminophen in two rabbits. At present, we have no explanation for the fact that these drugs suppress the pyrogenic effects of AcMur-Ala-iGln when it is delivered intravenously but not when it is delivered intraventricularly in rabbits. For purposes ofthe present paper, however, it is sufficient to note that the somnogenic effect of intravenously administered AcMur-Ala-iGln can be dissociated from its pyrogenic effect by prior treatment with acetaminophen.
Effects of Some AcMur-Ala-iGln Derivatives. Several AcMur-Ala-iGln derivatives were infused intraventricularly into rabbits with a view to determining (i) relationships between structure of muramyl peptides and somnogenic activity and (ii) whether some derivatives might be found that would induce sleep without fever. The results are summarized in Table 2 and compared with the effects of AcMur-Ala-iGln and AcMur-AlaiGln-Lys. The stereoisomers of AcMur-Ala-iGln (DD and LL) are nonpyrogenic and they failed to induced sleep; they are also ineffective as immunostimulants (5, 15) . The methyl and n-butyl esters and the N-Me derivative of AcMur-Ala-iGln are immunostimulants but they have no pyrogenic or somnogenic effects. Similar results were obtained after intravenous injection of 500 ,ug of the methylated derivatives. The muramyl moiety of AcMur-Ala-iGln was cleaved by gentle periodate oxidation to remove carbons 5 and 6 from the glucosamine ring. This treatment abolished the somnogenic effect, indicating that the muramyl component plays an essential role in the biological activity. However, N-acetylmuramic acid by itselfhad no effect on sleep.
DISCUSSION
Muramyl dipeptide was first synthesized with a view to determining the simplest chemical structure capable of mimicking the immunostimulatory properties of the bacterial peptidoglycans (6) . Subsequent work showed that AcMur-Ala-iGln and several of its derivatives are pyrogenic, although some derivatives that are immunostimulants are not pyrogens (7) . The pyrogenic effects of systemically administered AcMur-Ala-iGln may be mediated by formation of leukocytic pyrogens (14) but 
